Bcl-X/s (AA 120-130) Antikörper
-
- Target
- Bcl-X/s
- Bindungsspezifität
- AA 120-130
- Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Aufreinigung
- Antigen affinity
- Immunogen
- Amino acids 120-130 (YQSFEQDTFVE-human) were used as the immunogen for this Bcl-XS antibody.
- Isotyp
- IgG
-
-
- Applikationshinweise
- The stated application concentrations are suggested starting points. Titration of the Bcl-XS antibody may be required due to differences in protocols and secondary/substrate sensitivity.\. Western blot: 0.5-1 μg/mL,IHC (Paraffin): 0.5-1 μg/mL
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water
- Lagerung
- -20 °C
- Informationen zur Lagerung
- After reconstitution, the Bcl-XS antibody can be stored for up to one month at 4°C. For long-term, aliquot and store at -20°C. Avoid repeated freezing and thawing.
-
- Target
- Bcl-X/s
- Andere Bezeichnung
- Bcl-XS
- Hintergrund
- Bcl-XS is the second mRNA species of Bcl-X protein, which encodes a protein that inhibits the ability of Bcl-2 to enhance the survival of growth factor-deprived cells. In vivo, Bcl-XS mRNA is expressed at high levels in cells that undergo a high rate of turnover, such as developing lymphocytes. Apoptosis was associated with increased protein expression of Bcl-XS, an early marker of apoptosis, and release of Cytochrome C into the cytosol of infected HB cells.
- UniProt
- Q07817
-